APA (7th ed.) Citation

D, L., O, A., T, S., J, K., I, E., T, H., . . . W, B. (2013). Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases. Annals of the New York Academy of Sciences, 1291, 14. https://doi.org/10.1111/nyas.12122

Chicago Style (17th ed.) Citation

D, Lebwohl, Anak O, Sahmoud T, Klimovsky J, Elmroth I, Haas T, Posluszny J, Saletan S, and Berg W. "Development of Everolimus, a Novel Oral MTOR Inhibitor, Across a Spectrum of Diseases." Annals of the New York Academy of Sciences 1291 (2013): 14. https://doi.org/10.1111/nyas.12122.

MLA (9th ed.) Citation

D, Lebwohl, et al. "Development of Everolimus, a Novel Oral MTOR Inhibitor, Across a Spectrum of Diseases." Annals of the New York Academy of Sciences, vol. 1291, 2013, p. 14, https://doi.org/10.1111/nyas.12122.